TNF blocker safety may differ in RA and psoriasis patientsJune 14, 2016Rheumatoid ArthritisSpondyloarthropathiesPsoriatic Arthritis
Early identification, treatment still key to early arthritis guidelinesJune 12, 2016Rheumatoid Arthritis
VIDEO: Smoking, excess weight hinder sustained remission in early RAJune 10, 2016Rheumatoid Arthritis
Doctors ask Congress to stop Part B drug payment testMay 17, 2016SpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisBusiness of Medicine
PIANO study provides insight on safety of biologics in pregnancyMay 11, 2016Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Remicade to infliximab biosimilar switches fare well in real-life practiceMay 3, 2016SpondyloarthropathiesRheumatoid ArthritisAnkylosing spondylitisPsoriatic Arthritis
After Inflectra’s approval, challenges remain for biosimilarsApril 26, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisLupus & Connective Tissue DiseasesPediatricsSpondyloarthropathies
Imaging can predict who’ll progress from nonspecific symptoms to arthritisApril 26, 2016ImagingRheumatoid Arthritis
